In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy to meet you at “8th Bioproduction congress“ on thursday and friday in Lyon, France. If Read more…
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Compiègne (UTC) using the BIOMIMESYS® Liver hydroscaffold™ and HepG2/C3A (hepatocellular Read more…
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Asia. Our innovative and reliable 3D cell culture system is adapted to high throughput formats Read more…
The great meeting for the cosmetic field “Cosmetic 360” is back again ! Oceane GUYOT our project manager in dermocosmetology and Rita HIEN our business developper will be at this event on the 18th/19th and are looking forward to see you there. Do not hesitate to solicit us if you Read more…
HCS Pharma is speeding up its expansion into Asia ! Our CEO/CSO Mme. Nathalie MAUBON will again be in Asia and speak for the first time in China ! Mme. MAUBON will deliver a speech at Shanghai Zhangjiang Life Science International Innovation Summit on the 27th September and participate in Read more…
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D hydroscaffold matrix BIOMIMESYS® could be useful for bioproduction and then for cell therapy. We will be happy to meet you at ELRIG congress “Advancements in cell & Read more…
Find out more about BIOMIMESYS® and its wide range of applications (oncology, neurosciences, metabolism, adipocyte research) in this informative article. A comprehensive article describing the benefits of our products and the importance of results in research projects. For any question about our products, please feel free to contact us at Read more…
Skin redness is a sign of cutaneous inflammation which can lead to major skin disorders. When the skin is exposed to allergens, irritants, pathogens, or UV rays, cells produce a variety of inflammatory cytokines which bind to specific receptors on target cells. This binding stimulates the production of additional inflammatory signals, playing a key Read more…
Positive thinking = positive living ! Welcome back to work ! HCS Pharma wishes you a safe return to work and stay available to advice you about how our breaktrough 3D technologies BIOMIMESYS® declined for multiple specific research field can make your return to work smoother. Do not hesitate to Read more…
Thomas Meynard is a PhD student in OncoLille Laboratory (Canther Lab, Mucine Team), under the supervision of Dr. Isabelle Van Seuningen and Dr. Vincent Senez. His PhD work is focused on the development of microfluidic systems to study Pancreatic Ductal AdenoCarcinoma (PDAC). To reproduce the tumoral Extracellular Matrix (ECM), he Read more…
In Asia for a business trip, Nathalie Maubon, PhD, CEO & CSO of HCS Pharma, participated in a symposium during BioAsia event on late July, together with LumiSTAR Biotechnology (Taïwan) and Molecular Devices (USA). On this occasion, the 3 companies have highlighted their work on hiPSCs (human induced Pluripotent Stem Read more…
Rehovot (Israel) London (UK) and Lille (France) Vidac Pharma is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. Vidac Pharma and HCS Pharma announce cooperative agreement on acceleration of pre-clinical assays for Vidac Pharma Read more…
We are happy to share that Nathalie Maubon, PhD, our CEO/CSO is currently attending BioAsia Taiwan, organized in Taipei. The event aims at building on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities Read more…
Organisms store lipids when they consume more energy than they can use immediately. In mammals, adipose tissue, in addition to its role as an endocrine organ, is specialized in fat storage. Adipose tissue is mainly composed of adipocytes. Until recently, adipocytes were primarily considered mere reservoirs of energy stored as Read more…
Julien Cicero, with whom we are collaborating about the study of breast cancer metastasis mechanisms, was proud to present his PhD work during the last EACR conference. It was held in Torino (Italy) last month, during which Julien could discuss with cancer researchers from all around the world. His poster Read more…
Chez HCS Pharma, nous sommes ravis de partager avec vous les avancées significatives que nous avons réalisées dans nos projets de recherche et développement. Avant de commencer, nous tenons à remercier “La Gazette du Laboratoire” pour leur soutien continu et leur couverture détaillée de nos efforts. Notre entreprise, basée à Read more…
We are really pleased to announce that we will be present in BioAsia-Taiwan and present our breakthrough technology BIOMIMESYS alongside our partners Molecular Devices (USA) and LumiSTAR Biotechnology (TW). We are 3 companies in 3 different continents unifying their strenghs to develop the best strategy to find new and more Read more…
Our BIOMIMESYS® Adipose tissue extracellular matrix expands our 3D study possibilities ! HCS Pharma offers you a new 3D test for the evaluation of slimming properties of your actives ingredients. It offers you the possibility to observe the fat-inhibiting potential of your compounds. Adipose tissue is mainly composed of mature Read more…
After Japan, the business trip has been been continued in Taïwan for several days! As a scientist, I was really happy to see such open-mind spirit when I present BIOMIMESYS technology and how this kind of technology will change the drug discovery process and help the cell therapy/regenerative medicine in Read more…
Last week, we had the pleasure to participate in the conference about Alternatives to Animal Experimentation which was held last week in Biocitech park, Romainville, France. It was organized by Adebiotech think tank, and gathered researchers from private companies and academia, and also people from organizations like FC3R and PETA Read more…
Currently in Japan, it’s already been a week in Asia. Time goes by very quickly with 3 days of events, many appointments, visits from potential partners, a visit to the Kobe biopark and JETRO, and work appointments with our privileged partner, AS ONE.The 3 days in IDDST 2023 events in Read more…
This week we pleased to take part to the Imaging User Meeting 2023 of Molecular Devices. The event took place on 9 and 10 May in Copenhagen. It was an amazing opportunity to share our imaging practices with attendees and the scientific community. We appreciated the program, gathering a variety Read more…